Rituximab trial remissions suggest CFS is an autoimmune illness – for subset …ProHealthBenefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study – Source: PLo…
The Zacks Analyst Blog Highlights: Abbott Labs, Bristol-Myers Squibb, Biogen …PR Newswire (press release)Abbott Labs, along with partner Biogen (Nasdaq: BIIB), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple …
Dr. Bradstreet, Nagalase, and the Viral Issue in AutismAge of AutismSymptoms of the disease eased in 10 of 15 patients given rituximab, an anti-lymphoma drug. Rituximab works by destroying white blood cells that make antibodies, called B cells. The res…
USA TodayAbbott Laboratories' CEO Discusses Q3 2011 Results – Earnings Call TranscriptSeeking AlphaDaclizumab, our next generation biologic for MS is in Phase III development. Our recently announced results from our Phase II registrational trial su…
Chronic fatigue syndrome eased by cancer drugNew ScientistSymptoms of the disease eased in 10 of 15 patients given rituximab, an anti-lymphoma drug. Rituximab works by destroying white blood cells that make antibodies, called B cells. The results of th…
Deutsche Bank (DB) Analysts Reiterate a "Buy" Rating on Biogen Idec (BIIB)LocalizedUSAIt includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interferon beta-1…
Natco inks deal with Mabxience to manufacture mAb drugsPharmaceutical Business ReviewThree of the four products including Trastuzumab, Bevacizumab, Rituximab belong to the oncology segment, while Etanercept is used to treat auto-immune disease. As per …
Zimbabwe: Tongai Was More Than a Friend – PedroAllAfrica.comConcerted effort by the doctors to flush out his kidneys before administering the Rituximab drug to treat his non-Hodgkins lymphoma came to naught. "It was a little too late as the tumour…
Insciences OrganisationHalozyme gets boost from injectable HerceptinFierceDrugDeliveryRoche and Halozyme are also applying the technology to a formulation of Roche's cancer drug rituximab and testing it in trials for patients with certain forms of …
Moneycontrol.comNatco to enter bio-generics; signs up with MabxienceHindu Business LineThree of these products—Tastuzumab, Bevacizumab and Rituximab — belong to the oncology segment, while Etanercept is for auto-immune disorders. Biogenerics are bi…